Others
-
Others Related Products (76257)
Related Products (76257)
-
DSG-PEG1000-OH
0 ImagesCat. No.: HY-183132DSG-PEG1000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG1000-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
-
DSG-PEG2000-OH
0 ImagesCat. No.: HY-183132ADSG-PEG2000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG2000-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
-
DSG-PEG3400-OH
0 ImagesCat. No.: HY-183132BDSG-PEG3400-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG3400-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
-
DSG-PEG5000-OH
0 ImagesCat. No.: HY-183132CDSG-PEG1000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DMG-PEG1000-Glucose combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
-
DSG-PEG10000-OH
0 ImagesCat. No.: HY-183132DDSG-PEG10000-OH is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal hydroxyl groups (-OH). DSG-PEG10000-OH combines the membrane compatibility of phospholipids with the flexibility of hydroxyl modification, making it suitable for research in biomaterial construction and drug delivery.
-
C16-PEG2000-COOH
0 ImagesCat. No.: HY-183133C16-PEG2000-COOH is a conjugate composed of a hexadecyl (C16 aliphatic chain), a PEG chain, and a carboxyl group (-COOH). C16-PEG2000-COOH combines the membrane compatibility of lipids with the carboxyl group, which can form amide bonds with primary amines via EDC/NHS activation, making it suitable for research in biomaterial construction and drug delivery.
-
C16-PEG3400-COOH
0 ImagesCat. No.: HY-183133AC16-PEG3400-COOH is a conjugate composed of a hexadecyl (C16 aliphatic chain), a PEG chain, and a carboxyl group (-COOH). C16-PEG3400-COOH combines the membrane compatibility of lipids with the carboxyl group, which can form amide bonds with primary amines via EDC/NHS activation, making it suitable for research in biomaterial construction and drug delivery.
-
C16-PEG5000-COOH
0 ImagesCat. No.: HY-183133BC16-PEG5000-COOH is a conjugate composed of a hexadecyl (C16 aliphatic chain), a PEG chain, and a carboxyl group (-COOH). C16-PEG5000-COOH combines the membrane compatibility of lipids with the carboxyl group, which can form amide bonds with primary amines via EDC/NHS activation, making it suitable for research in biomaterial construction and drug delivery.
-
C16-PEG2000-NHS
0 ImagesCat. No.: HY-183134C16-PEG2000-NHS is a conjugate composed of hexadecyl (C16, i.e., palmitoyl), a PEG chain, and an active ester (NHS). C16-PEG2000-NHS combines the membrane compatibility of lipids with glucose as an active site for sugar recognition or subsequent conjugation reactions, making it suitable for research in biomaterial construction and drug delivery.
-
C16-PEG3400-NHS
0 ImagesCat. No.: HY-183134AC16-PEG3400-NHS is a conjugate composed of hexadecyl (C16, i.e., palmitoyl), a PEG chain, and an active ester (NHS). C16-PEG3400-NHS combines the membrane compatibility of lipids with glucose as an active site for sugar recognition or subsequent conjugation reactions, making it suitable for research in biomaterial construction and drug delivery.
-
C16-PEG5000-NHS
0 ImagesCat. No.: HY-183134BC16-PEG5000-NHS is a conjugate composed of hexadecyl (C16, i.e., palmitoyl), a PEG chain, and an active ester (NHS). C16-PEG5000-NHS combines the membrane compatibility of lipids with glucose as an active site for sugar recognition or subsequent conjugation reactions, making it suitable for research in biomaterial construction and drug delivery.
-
C16-PEG2000-Mal
0 ImagesCat. No.: HY-183135C16-PEG2000-Mal is a conjugate composed of a hexadecyl (C16 aliphatic chain), a PEG chain, and maleimide (Mal). C16-PEG2000-Mal combines the membrane compatibility of lipids with the specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), making it suitable for research in biomaterial construction and drug delivery.
-
C16-PEG3400-Mal
0 ImagesCat. No.: HY-183135AC16-PEG3400-Mal is a conjugate composed of a hexadecyl (C16 aliphatic chain), a PEG chain, and maleimide (Mal). C16-PEG3400-Mal combines the membrane compatibility of lipids with the specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), making it suitable for research in biomaterial construction and drug delivery.
-
C16-PEG5000-Mal
0 ImagesCat. No.: HY-183135BC16-PEG5000-Mal is a conjugate composed of a hexadecyl (C16 aliphatic chain), a PEG chain, and maleimide (Mal). C16-PEG5000-Mal combines the membrane compatibility of lipids with the specific Michael addition reaction with thiol-containing (-SH) biomolecules (such as peptides, antibodies, and aptamers), making it suitable for research in biomaterial construction and drug delivery.
-
DMG-PEG1000-Glucose
0 ImagesCat. No.: HY-183156DMG-PEG1000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG1000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
-
DMG-PEG2000-Glucose
0 ImagesCat. No.: HY-183156ADMG-PEG2000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG2000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
-
DMG-PEG3400-Glucose
0 ImagesCat. No.: HY-183156BDMG-PEG3400-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG3400-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
-
DMG-PEG5000-Glucose
0 ImagesCat. No.: HY-183156CDMG-PEG5000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG5000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
-
DMG-PEG10000-Glucose
0 ImagesCat. No.: HY-183156DDMG-PEG10000-Glucose is a conjugate composed of dimyristic glycerol (DMG), a PEG chain, and terminal glucose. DMG-PEG10000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
-
DSG-PEG1000-Glucose
0 ImagesCat. No.: HY-183159DSG-PEG1000-Glucose is a conjugate composed of DSG, a PEG chain, and terminal glucose. DSG-PEG1000-Glucose combines the membrane compatibility of phospholipids with glucose as an active site for sugar recognition or subsequent coupling reactions, making it suitable for research in biomaterial construction and drug delivery.
